Waverly Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $505K | Sell |
13,142
-237
| -2% | -$9.1K | 0.01% | 791 |
|
|
2025
Q1 | $518K | Buy |
13,379
+146
| +1% | +$5.66K | 0.01% | 761 |
|
|
2024
Q4 | $448K | Buy |
13,233
+7,025
| +113% | +$238K | 0.01% | 707 |
|
|
2024
Q3 | $254K | Sell |
6,208
-851
| -12% | -$34.8K | ﹤0.01% | 722 |
|
|
2024
Q2 | $272K | Buy |
7,059
+73
| +1% | +$2.81K | 0.01% | 687 |
|
|
2024
Q1 | $299K | Buy |
6,986
+869
| +14% | +$37.3K | 0.01% | 571 |
|
|
2023
Q4 | $227K | Buy |
+6,117
| New | +$227K | 0.01% | 398 |
|
|
2018
Q1 | – | Sell |
-139
| Closed | -$6K | – | 262 |
|
|
2017
Q4 | $6K | Buy |
+139
| New | +$6K | ﹤0.01% | 360 |
|
|
2015
Q1 | – | Sell |
-174
| Closed | -$9K | – | 374 |
|
|
2014
Q4 | $9K | Sell |
174
-1,096
| -86% | -$56.7K | ﹤0.01% | 325 |
|
|
2014
Q3 | $73K | Sell |
1,270
-240
| -16% | -$13.8K | 0.04% | 175 |
|
|
2014
Q2 | $101K | Buy |
1,510
+670
| +80% | +$44.8K | 0.04% | 147 |
|
|
2014
Q1 | $56K | Buy |
840
+64
| +8% | +$4.27K | 0.03% | 211 |
|
|
2013
Q4 | $52K | Buy |
776
+291
| +60% | +$19.5K | 0.02% | 326 |
|
|
2013
Q3 | $30K | Buy |
+485
| New | +$30K | 0.02% | 309 |
|